Active

ChemoSensoryX Biosciences SA

Switched

BE0867817428

Rechtspersoon Public limited company 1 establishment

Avenue Jean Monnet 1, 1348 Ottignies-Louvain-la-Neuve Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

21 year, 10 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -597,516

▼ 12096% vs 2024

Profit

Caution

€ -1.4 million

▼ 26941% vs 2024

Debts

High

€ 2 million

▲ 929571% vs 2024

ChemoSensoryX Biosciences SA from Ottignies-Louvain-la-Neuve, company number BE0867817428, closed financial year 2025 with a result of € -1.4 million after tax. For that financial year ChemoSensoryX Biosciences SA recorded a gross margin of € -597,516 and equity of € -441,906. Compared with financial year 2024, the result moved from € -5,029 to € -1.4 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What happened at ChemoSensoryX Biosciences SA?

What happened at ChemoSensoryX Biosciences SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Guillaume Tardif stepped down as director. NBB
  • Bernard Boulin stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 1.4 million. Source: NBB ↗
  • ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION ASBL (A.M.I.R.) stepped down as director. NBB
  • Guillaume Tardif became a director. NBB
  • Bernard Boulin became a director. NBB
  • COVORIM BV stepped down as director. NBB
  • ASSOCIATION RECHERCHE BIOMEDICALE ET DIAGNOSTIC (A.R.B.D.) stepped down as director. NBB

In short

From € 466 loss in 2022 to € 1.4 million loss in 2025.

Paid € 2 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

A new publication or filing at ChemoSensoryX Biosciences SA? We notify you, reason included.

Follow ChemoSensoryX Biosciences SA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION ASBL (A.M.I.R.)

Director · represented by Joelle Dumont

Also active at: CHEMCOM

since 2024 · until 2025

Guillaume Tardif

Director

since 2025 · until 2031

Bernard Boulin

Director

since 2025 · until 2031

COVORIM BV

Director · represented by Benedikt Van Der Vorst

Also active at: CHEMCOM, Allegro Investment Fund

since 2024 · until 2025

ASSOCIATION RECHERCHE BIOMEDICALE ET DIAGNOSTIC (A.R.B.D.)

Director · represented by Gilbert Vassart

since 2024 · until 2025

Bernard Delwart

Director

since 2024 · until 2025

CONTHEGAS CONSULTING SRL

Director · represented by Jean-François Pollet

Also active at: CHEMCOM

since 2024 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Jean Monnet 1

1348 Ottignies-Louvain-la-Neuve

2.248.163.852

Drève Richelle 161P box 4

1410 Waterloo

Active since 13 October 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.

BETA Systems Software

€ 169,402 gross margin · 2025

AIR VISION

€ 71,505 gross margin · 2025

HEXION RESEARCH BELGIUM SA

€ 2.5 million gross margin · 2025

FEMAG

€ -13,629 gross margin · 2025

CHEMIUM

€ 277,473 gross margin · 2025

+12 more

Details

Company number
0867.817.428
VAT number
BE 0867.817.428
Registered office
Avenue Jean Monnet 1, 1348 Ottignies-Louvain-la-Neuve
Names & denominations
ChemoSensoryX Biosciences SA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
13 October 2004
Peppol
Active · Active since 25 Nov 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Bemiddeling in verband met exploitatie van en handel in onroerend goed

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of ChemoSensoryX Biosciences SA?
The enterprise number of ChemoSensoryX Biosciences SA is BE0867817428.
What is the address of ChemoSensoryX Biosciences SA?
The registered office of ChemoSensoryX Biosciences SA is located at Avenue Jean Monnet 1, 1348 Ottignies-Louvain-la-Neuve.
When was ChemoSensoryX Biosciences SA founded?
ChemoSensoryX Biosciences SA was founded on 13 October 2004.
What is the main activity of ChemoSensoryX Biosciences SA?
The main activity of ChemoSensoryX Biosciences SA is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does ChemoSensoryX Biosciences SA have a website?
No website is currently known for ChemoSensoryX Biosciences SA.
How much profit did ChemoSensoryX Biosciences SA make in 2025?
ChemoSensoryX Biosciences SA recorded a loss after taxes of € 1,359,953 in financial year 2025.
What is the revenue of ChemoSensoryX Biosciences SA?
As a small company, ChemoSensoryX Biosciences SA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -597,516.
Where can I find the annual accounts of ChemoSensoryX Biosciences SA?
ChemoSensoryX Biosciences SA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ChemoSensoryX Biosciences SA?
According to the 2025 annual accounts, the directors of ChemoSensoryX Biosciences SA are: ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION ASBL (A.M.I.R.), Guillaume Tardif, Bernard Boulin, COVORIM BV, ASSOCIATION RECHERCHE BIOMEDICALE ET DIAGNOSTIC (A.R.B.D.), Bernard Delwart, CONTHEGAS CONSULTING SRL.